FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

Directions to Sponsors of
Emergency Investigational New Drug (EIND) Applications
Office of Antimicrobial Products, Division of Antiviral Products

1. Complete the following forms:

  • Emergency Investigational New Drug Application (EIND) Information Request Form [PDF] [Word]
  • Form FDA 1571 [PDF] [Word]
  • Form FDA 1572 [PDF] [Word]

2. Fax the completed paperwork to (301)796-9883, along with a CV of the primary investigator. Please call to inform us the fax has been sent.

3. Once we receive the completed forms and a Medical Officer approves them, you will be contacted with an EIND number. Please include a telephone number where you can be reached along with a fax number.

4. Mail the original forms and two (2) copies to:

Food & Drug Administration
Center for Drug Evaluation and Research
Division of Antiviral Products
5901-B Ammendale Road
Beltsville, MD   20705-1266

If you have any questions please call (301)796-1500.

5. To obtain an EIND after regular business hours (8:00 am – 4:30 pm EST) please call (301) 443-1240. You will be placed into contact with a member of the Division of Antiviral Products.

Division of Antiviral Products

Director: Debra Birnkrant, M.D.
Deputy Director: Jeffery Murray, M.D., M.P.H.
Chief, Project Management Staff: Karen Winestock

White Oak
Building #22, Room 6329
10903 New Hampshire Avenue
Silver Spring, MD 20993
Phone: (301) 796-1500

Back to Top     Back to IND Applications

PDF requires the free Adobe Acrobat Reader

Date created: November 29, 2005, updated June 5, 2008

horizonal rule